7.
Long-Term Debt


Credit Agreement



On June 14, 2022, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent, which amended and restated the 2018 Credit Agreement. The Credit Agreement provides for a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years.  Both facilities bear interest at the SOFR, plus a margin based on the Company’s consolidated leverage ratio. Commitment fees payable under the Credit Agreement are also based on the consolidated leverage ratio as defined in the Credit Agreement and range from 0.175% to 0.30% on the unused portion of the total lender commitments then in effect. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement is guaranteed by certain of the Company’s domestic subsidiaries and collateralized by assets of such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of December 31, 2024, the Company was in compliance with all covenants under the Credit Agreement.

The following table summarizes the Company’s debt facilities as of December 31, 2024 and 2023:

Facility or Arrangement
 
Original
Principal
Amount
 
Balance as of
December 31,
2024 (1)(2)
 
Balance as of
December 31,
2023 (1)(2)
 
Interest
Rate
 
Repayment
Terms
Credit Agreement term loan facility
 
$400.0 million
 
$360.0 million
 
 
$385.0 million
 
Variable 30 day: 6.71%
 
21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.
                     
Credit Agreement revolving credit facility
     
$35.0 million
 
$120.0 million
 
Variable 30 day: 6.71%
 
Revolving line of credit expires June 14, 2027.

(1)
As of December 31, 2024 and 2023, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $20.0 million and $25.0 million, respectively, of the balance of its term loan under the Credit Agreement and $10.0 and $0, respectively, of the balance under the revolving line of credit.

(2)
The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $1.4 million and $2.0 million as of December 31, 2024 and 2023, respectively, related to the Credit Agreement, which are not reflected in this table.

Maturities of all long-term debt at December 31, 2024, are as follows (U.S. dollars in thousands):

Year Ending December 31,
     
2025
 
$
30,000
 
2026
   
20,000
 
2027
   
345,000
 
2028
   
 
2029
   
 
Thereafter
   
 
Total (1)
 
$
395,000
 

(1)
The carrying value of the debt in the above table excludes debt issuance costs of $1.4 million.

Historical Timeline

Fiscal YearFiled
2024Feb 14, 2025Showing above
2023Feb 15, 2024
2022Feb 16, 2023
2021Feb 16, 2022
2020Feb 11, 2021
2019Feb 13, 2020
2018Feb 14, 2019
2017Feb 16, 2018
2016Feb 27, 2017
2015Feb 18, 2016

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.